{"id":"https://openalex.org/W4415404129","doi":"https://doi.org/10.64719/pb.6848","title":"Recent Advances in the Neurobiology of Depression","display_name":"Recent Advances in the Neurobiology of Depression","publication_year":2015,"publication_date":"2015-12-16","ids":{"openalex":"https://openalex.org/W4415404129","doi":"https://doi.org/10.64719/pb.6848","mag":"90311496","pmid":"https://pubmed.ncbi.nlm.nih.gov/12490820"},"language":"en","primary_location":{"id":"doi:10.64719/pb.6848","doi":"https://doi.org/10.64719/pb.6848","is_oa":false,"landing_page_url":"https://doi.org/10.64719/pb.6848","pdf_url":null,"source":{"id":"https://openalex.org/S5407052355","display_name":"Psychopharmacology Bulletin","issn_l":"0048-5764","issn":["0048-5764","2472-2448"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["medline","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5120085574","display_name":"By Charles B. Nemeroff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"By Charles B. Nemeroff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020295735","display_name":"William M. Greenberg","orcid":"https://orcid.org/0000-0002-3507-8268","observed_orcids":["https://orcid.org/0000-0002-3507-8268"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MD","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"PhD","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"PhD","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.5684,"has_fulltext":false,"cited_by_count":145,"citation_normalized_percentile":{"value":0.95039614,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"36","issue":"Suppl. 2","first_page":"6","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8208000063896179,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8208000063896179,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.12809999287128448,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10529","display_name":"Stress Responses and Cortisol","score":0.016300000250339508,"subfield":{"id":"https://openalex.org/subfields/2802","display_name":"Behavioral Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8690000176429749},{"id":"https://openalex.org/keywords/neurobiology-of-depression","display_name":"neurobiology of depression","score":0.8240000009536743},{"id":"https://openalex.org/keywords/mood-disorders","display_name":"mood disorders","score":0.8130000233650208},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/serotonergic-system","display_name":"serotonergic system","score":0.9240000247955322},{"id":"https://openalex.org/keywords/noradrenergic-system","display_name":"noradrenergic system","score":1.0},{"id":"https://openalex.org/keywords/neurotransmitter-reuptake","display_name":"neurotransmitter reuptake","score":0.8889999985694885},{"id":"https://openalex.org/keywords/neurotransmitter-receptors","display_name":"neurotransmitter receptors","score":0.8309999704360962},{"id":"https://openalex.org/keywords/substance-p","display_name":"substance P","score":0.9079999923706055},{"id":"https://openalex.org/keywords/corticotropin-releasing-factor","display_name":"corticotropin-releasing factor","score":0.9150000214576721},{"id":"https://openalex.org/keywords/tachykinin-nk1-receptor-antagonists","display_name":"tachykinin NK1 receptor antagonist","score":0.9399999976158142},{"id":"https://openalex.org/keywords/crf1-receptor-antagonist","display_name":"CRF1 receptor antagonist","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antidepressant-mechanism-of-action","display_name":"antidepressant mechanism","score":0.7730000019073486}],"concepts":[{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.8773999810218811},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.6938999891281128},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6607000231742859},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.6420999765396118},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.5899999737739563},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5074999928474426},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.47530001401901245},{"id":"https://openalex.org/C3017459112","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter systems","level":3,"score":0.4722999930381775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46860000491142273},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.4438000023365021},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.41600000858306885},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.4131999909877777},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.40130001306533813},{"id":"https://openalex.org/C2777134132","wikidata":"https://www.wikidata.org/wiki/Q188638","display_name":"Mood disorders","level":3,"score":0.39879998564720154},{"id":"https://openalex.org/C2910715078","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter Agents","level":4,"score":0.39570000767707825},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.38679999113082886},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.38179999589920044},{"id":"https://openalex.org/C156927020","wikidata":"https://www.wikidata.org/wiki/Q1187783","display_name":"Neurotransmitter receptor","level":3,"score":0.36629998683929443},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3440000116825104},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.34380000829696655},{"id":"https://openalex.org/C2780375056","wikidata":"https://www.wikidata.org/wiki/Q905905","display_name":"Neuromodulation","level":3,"score":0.34369999170303345},{"id":"https://openalex.org/C2778875871","wikidata":"https://www.wikidata.org/wiki/Q4764954","display_name":"Animal models of depression","level":4,"score":0.33480000495910645},{"id":"https://openalex.org/C10162356","wikidata":"https://www.wikidata.org/wiki/Q1135939","display_name":"Pathophysiology","level":2,"score":0.3197000026702881},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.31859999895095825},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.28870001435279846},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.2872999906539917},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.2766999900341034},{"id":"https://openalex.org/C128188215","wikidata":"https://www.wikidata.org/wiki/Q3026765","display_name":"Neuropharmacology","level":2,"score":0.2587999999523163},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.2583000063896179},{"id":"https://openalex.org/C49467328","wikidata":"https://www.wikidata.org/wiki/Q5376333","display_name":"Endogenous depression","level":3,"score":0.25200000405311584}],"mesh":[{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":true},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D013373","descriptor_name":"Substance P","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013373","descriptor_name":"Substance P","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018019","descriptor_name":"Receptors, Corticotropin-Releasing Hormone","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.64719/pb.6848","doi":"https://doi.org/10.64719/pb.6848","is_oa":false,"landing_page_url":"https://doi.org/10.64719/pb.6848","pdf_url":null,"source":{"id":"https://openalex.org/S5407052355","display_name":"Psychopharmacology Bulletin","issn_l":"0048-5764","issn":["0048-5764","2472-2448"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["medline","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology Bulletin","raw_type":"journal-article"},{"id":"pmid:12490820","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12490820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Journal Article"},{"id":"mag:90311496","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12490820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W87642065","https://openalex.org/W2471913816","https://openalex.org/W2167794385","https://openalex.org/W1520636085","https://openalex.org/W1696476660","https://openalex.org/W2004974601","https://openalex.org/W2148535867","https://openalex.org/W2028860498","https://openalex.org/W1909143486","https://openalex.org/W6989724262"],"abstract_inverted_index":{"Elucidation":[0],"of":[1,5,23,38,74,86,98,101,118,128,144,159],"the":[2,20,30,36,58,70,83,99,116,125,145,155],"neurobiological":[3,147],"basis":[4],"depression":[6,151],"and":[7,16,25,48,54,65,80,110,134,157],"other":[8],"mood":[9,119],"disorders":[10],"is":[11],"rapidly":[12],"increasing.":[13],"Considerable":[14],"experimental":[15],"clinical":[17,126],"evidence":[18,41],"supports":[19],"fundamental":[21],"roles":[22],"serotonin":[24],"norepinephrine,":[26],"as":[27,29],"well":[28],"interactions":[31],"between":[32],"these":[33,102],"systems":[34],"in":[35,46,62,69,115,139,150],"etiology":[37],"depression.":[39,78],"Substantial":[40],"has":[42,152],"accrued,":[43],"including":[44],"changes":[45,95,148],"neurotransmitter":[47,49],"metabolite":[50],"concentrations,":[51],"reuptake":[52],"sites,":[53],"receptors,":[55],"to":[56],"support":[57],"hypothesis":[59],"that":[60],"alteration":[61],"neuronal":[63],"serotonergic":[64],"noradrenergic":[66],"function":[67],"occurs":[68],"central":[71],"nervous":[72],"system":[73],"patients":[75],"with":[76],"major":[77,84],"Serotonin":[79],"norepinephrine":[81],"represent":[82],"targets":[85],"current":[87],"therapeutic":[88],"interventions,":[89],"which":[90],"may":[91],"induce":[92],"longer-term":[93],"adaptive":[94],"via":[96],"modulation":[97],"activity":[100],"neurotransmitters.":[103],"In":[104],"addition,":[105],"two":[106],"neuropeptide":[107],"neurotransmitters--substance":[108],"P":[109],"corticotropin-releasing":[111],"factor--have":[112],"been":[113],"implicated":[114],"pathophysiology":[117],"disorders.":[120,141],"Preliminary":[121],"studies":[122],"have":[123],"reported":[124],"efficacy":[127],"a":[129,135],"tachykinin":[130],"NK1":[131],"receptor":[132,137],"antagonist":[133,138],"CRF1":[136],"depressive":[140],"Further":[142],"clarification":[143],"precise":[146],"occurring":[149],"implications":[153],"for":[154,163],"use":[156],"development":[158],"novel":[160],"effective":[161],"treatments":[162],"this":[164],"disorder.":[165]},"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2025-10-22T00:00:00"}